FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Immunocytochemistry Assay, P16/Ki-67
PMA: P190024
·
Supplement: S007
·
Decision Jul 29, 2022
Classifications
1
FEI Numbers
1
Registration Numbers
1
Basic Information
- Device Name
- Immunocytochemistry Assay, P16/Ki-67
- Trade Name
- CINtec PLUS Cytology
- PMA Number
- P190024
- Supplement Number
- S007
- Device Class
- FDA Class 3
- Product Code
- QKF
- Generic Name
- Immunocytochemistry assay, p16/Ki-67
- Regulation Number
- 864.1860
- Medical Specialty
- Hematology
- Advisory Committee
- Pathology
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- July 29, 2022
- Date Received
- July 12, 2022
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Addition of alternative suppliers for component parts.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| QKF | Immunocytochemistry Assay, P16/Ki-67 | FDA class 3 | Hematology |